Literature DB >> 4739402

Clindamycin-associated colitis.

L E Cohen, C J McNeill, R F Wells.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4739402

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  38 in total

Review 1.  Antibacterial drugs today. I.

Authors:  A P Ball; J A Gray; J M Murdoch
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 2.  Clindamycin--efficacy and toxicity.

Authors:  R I Frankel
Journal:  West J Med       Date:  1975-06

3.  Incidence and significance of intraperitoneal anaerobic bacteria.

Authors:  H H Stone; L D Kolb; C E Geheber
Journal:  Ann Surg       Date:  1975-05       Impact factor: 12.969

4.  Familial pseudomembranous colitis and its relation to lincomycin therapy.

Authors:  M J Harrod; M S Brown; A G Weinberg; W N Harkness; J L Goldstein
Journal:  Am J Dig Dis       Date:  1975-09

5.  Frontiers in inflammatory bowel disease. The proceedings of a conference sponsored by the McReynolds Foundation. Part 1.

Authors: 
Journal:  Am J Dig Dis       Date:  1975-06

6.  Clindamycin-associated colitis.

Authors:  F G Vescia
Journal:  West J Med       Date:  1976-06

7.  Ampicillin-associated diarrhea--A prospective study.

Authors:  F J Tedesco
Journal:  Am J Dig Dis       Date:  1975-04

8.  Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks.

Authors:  W W Laslie; D W Lambe
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

9.  Purified Clostridium difficile cytotoxin stimulates guanylate cyclase activity and inhibits adenylate cyclase activity.

Authors:  D L Vesely; K D Straub; C M Nolan; R D Rolfe; S M Finegold; T P Monson
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

10.  Factors influencing the phagocytosis of Clostridium difficile by human polymorphonuclear leukocytes.

Authors:  D C Dailey; A Kaiser; R H Schloemer
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.